IPTACOPAN TREATMENT IN PATIENTS WITH C3 GLOMERULOPATHY (C3G): 12-MONTH RESULTS FROM THE MANAGED ACCESS PROGRAM

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/bb8967a3495a65ddcf65e7f21b584e8b.pdf
IPTACOPAN TREATMENT IN PATIENTS WITH C3 GLOMERULOPATHY (C3G): 12-MONTH RESULTS FROM THE MANAGED ACCESS PROGRAM

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Carla M
Nester
Luigi Biancone luigi.biancone@gmail.com Città Della Salute e Della Scienza Hospital Division of Nephrology Dialysis and Transplantation Turin Italy -
Carla M Nester cnester@uiowa.edu Stead Family Children’s Hospital Division of Pediatric Nephrology Iowa City United States *
Miquel Blasco MIBLASCO@clinic.cat Nephrology and Urology Institute Hospital Clínic Department of Nephrology and Renal Transplantation Barcelona Spain -
Teresa Cavero tcaveroescribano@gmail.com Hospital Universitario 12 de Octubre Department of Nephrology Madrid Spain -
Gianluigi Ardissino ardissino@centroseu.org Ospedale Maggiore Policlinico Center for Hemolytic Uremic Syndrome (HUS) Prevention Milan Italy -
Soudeh Ansari soudeh.ansari@novartis.com Novartis Pharmaceuticals Corporation Global Drug Development Cambridge United States -
Sviatlana Rizk sviatlana.rizk@novartis.com Novartis Pharma AG Global Drug Development Basel Switzerland -
Roohi Chopra roohi.chopra@novartis.com Novartis Farmaceutica S.A. Global Drug Development Barcelona Spain -
Serge Smeets serge.smeets@novartis.com Novartis Pharma AG Global Drug Development Basel Switzerland -